Dr. Audrey Emily Kam, MD

Dr. Kam practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Kam's NPI, 1659635977, was assigned on July 2, 2012. Dr. Kam graduated from Wayne State University School Of Medicine in 2012. Dr. Kam holds Illinois license 036-145589.

Dr. Kam's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Kam's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Kam is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Kam to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kam practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kam's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kam is board certified in hematology by the American Board of Internal Medicine. Dr. Kam is licensed in Illinois.

Dmand AI lists breast cancer, colorectal cancer, deep vein thrombosis (DVT) and lung cancer among the conditions Dr. Kam treats.

CMS data shows 781 Medicare services from Dr. Kam across 5 procedure codes in 2024, for 116 Medicare patients. Medicare paid $52,854 for them.

CMS counts 116 Medicare patients who saw Dr. Kam in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kam's median patient age at 70, with 47% women.

In 2024, Dr. Kam wrote 356 Medicare Part D claims for 73 patients. 86% of them were for generic drugs. CMS names the drug for 213 of them, across 6 drugs with 11 or more claims each, at $45,040 in total drug cost. In 2023, CMS named 133 claims across 5 drugs.

Dr. Kam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kam as offering telehealth.

Dmand AI links 8 papers to Dr. Kam, published from 2018 to 2022. 2021 was the busiest year, with 3. The most frequent topics are Colorectal Neoplasms and Palliative Care. Dr. Kam has published most often in Genome Biol. Dr. Kam's most frequent co-authors are Timothy M. Kuzel, MD, Sam George Pappas, MD and Bassel Fouad El-Rayes, MD.

CMS Open Payments shows 19 general payments to Dr. Kam from 12 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 81% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $1,588.

Dr. Kam graduated from Wayne State University School Of Medicine in 2012.

Dr. Kam is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.